Sanofi SA ADR
SNY: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| Z$ | LOCK|&Z<T | LOCK|>cl@^D |
Sanofi's New Leadership Faces Looming Patent Cliff
Business Strategy and Outlook
Sanofi's wide lineup of branded drugs and vaccines and robust pipeline creates strong cash flows and a narrow economic moat.
